USANA Health Sciences, Inc.
USNA
$30.02
$0.521.76%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.69% | -7.22% | -7.10% | -7.67% | -7.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.69% | -7.22% | -7.10% | -7.67% | -7.56% |
| Cost of Revenue | -0.38% | -8.76% | -8.75% | -8.97% | -10.36% |
| Gross Profit | -3.23% | -6.86% | -6.70% | -7.36% | -6.88% |
| SG&A Expenses | 1.57% | -3.73% | -6.26% | -6.61% | -6.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16% | -4.80% | -6.80% | -7.12% | -7.24% |
| Operating Income | -36.94% | -28.74% | -9.92% | -12.54% | -10.35% |
| Income Before Tax | -34.71% | -25.48% | -6.20% | -6.79% | -2.67% |
| Income Tax Expenses | -20.33% | -11.31% | -1.64% | 3.79% | 1.43% |
| Earnings from Continuing Operations | -43.80% | -34.06% | -9.15% | -13.12% | -5.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.67% | -34.11% | -9.15% | -13.12% | -5.09% |
| EBIT | -36.94% | -28.74% | -9.92% | -12.54% | -10.35% |
| EBITDA | -25.53% | -23.55% | -8.33% | -11.14% | -9.88% |
| EPS Basic | -43.14% | -33.55% | -8.57% | -12.75% | -5.11% |
| Normalized Basic EPS | -33.99% | -24.89% | -5.58% | -6.38% | -2.68% |
| EPS Diluted | -43.46% | -33.79% | -8.50% | -12.70% | -5.12% |
| Normalized Diluted EPS | -33.81% | -24.90% | -5.52% | -6.54% | -2.98% |
| Average Basic Shares Outstanding | -0.89% | -0.87% | -0.69% | -0.44% | 0.01% |
| Average Diluted Shares Outstanding | -1.19% | -0.95% | -0.77% | -0.24% | 0.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |